keyword
https://read.qxmd.com/read/36325690/the-aacr-journals-advancing-progress-toward-the-aacr-s-115-year-mission
#1
JOURNAL ARTICLE
Kenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, Chi Van Dang, Luis A Diaz, Raymond N DuBois, Keith T Flaherty, Philip D Greenberg, Massimo Loda, Elaine R Mardis, Elizabeth A Platz, Michael N Pollak, Robert D Schreiber, Lillian L Siu, Beverly A Teicher
No abstract text is available yet for this article.
November 3, 2022: Molecular Cancer Therapeutics
https://read.qxmd.com/read/36325685/the-aacr-journals-advancing-progress-toward-the-aacr-s-115-year-mission
#2
JOURNAL ARTICLE
Kenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, Chi Van Dang, Luis A Diaz, Raymond N DuBois, Keith T Flaherty, Philip D Greenberg, Massimo Loda, Elaine R Mardis, Elizabeth A Platz, Michael N Pollak, Robert D Schreiber, Lillian L Siu, Beverly A Teicher
No abstract text is available yet for this article.
November 3, 2022: Molecular Cancer Research: MCR
https://read.qxmd.com/read/36321306/the-aacr-journals-advancing-progress-toward-the-aacr-s-115-year-mission
#3
JOURNAL ARTICLE
Kenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, Chi Van Dang, Luis A Diaz, Raymond N DuBois, Keith T Flaherty, Philip D Greenberg, Massimo Loda, Elaine R Mardis, Elizabeth A Platz, Michael N Pollak, Robert D Schreiber, Lillian L Siu, Beverly A Teicher
No abstract text is available yet for this article.
November 2, 2022: Cancer Discovery
https://read.qxmd.com/read/36321301/the-aacr-journals-advancing-progress-toward-the-aacr-s-115-year-mission
#4
JOURNAL ARTICLE
Kenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, Chi Van Dang, Luis A Diaz, Raymond N DuBois, Keith T Flaherty, Philip D Greenberg, Massimo Loda, Elaine R Mardis, Elizabeth A Platz, Michael N Pollak, Robert D Schreiber, Lillian L Siu, Beverly A Teicher
No abstract text is available yet for this article.
November 2, 2022: Cancer Epidemiology, Biomarkers & Prevention
https://read.qxmd.com/read/36321298/the-aacr-journals-advancing-progress-toward-the-aacr-s-115-year-mission
#5
JOURNAL ARTICLE
Kenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, Chi Van Dang, Luis A Diaz, Raymond N DuBois, Keith T Flaherty, Philip D Greenberg, Massimo Loda, Elaine R Mardis, Elizabeth A Platz, Michael N Pollak, Robert D Schreiber, Lillian L Siu, Beverly A Teicher
No abstract text is available yet for this article.
November 2, 2022: Cancer Immunology Research
https://read.qxmd.com/read/36321294/the-aacr-journals-advancing-progress-toward-the-aacr-s-115-year-mission
#6
JOURNAL ARTICLE
Kenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, Chi Van Dang, Luis A Diaz, Raymond N DuBois, Keith T Flaherty, Philip D Greenberg, Massimo Loda, Elaine R Mardis, Elizabeth A Platz, Michael N Pollak, Robert D Schreiber, Lillian L Siu, Beverly A Teicher
No abstract text is available yet for this article.
November 2, 2022: Blood cancer discovery
https://read.qxmd.com/read/36321264/the-aacr-journals-advancing-progress-toward-the-aacr-s-115-year-mission
#7
JOURNAL ARTICLE
Kenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, Chi Van Dang, Luis A Diaz, Raymond N DuBois, Keith T Flaherty, Philip D Greenberg, Massimo Loda, Elaine R Mardis, Elizabeth A Platz, Michael N Pollak, Robert D Schreiber, Lillian L Siu, Beverly A Teicher
No abstract text is available yet for this article.
November 2, 2022: Cancer Research
https://read.qxmd.com/read/36317374/the-aacr-journals-advancing-progress-toward-the-aacr-s-115-year-mission
#8
JOURNAL ARTICLE
Kenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, Chi Van Dang, Luis A Diaz, Raymond N DuBois, Keith T Flaherty, Philip D Greenberg, Massimo Loda, Elaine R Mardis, Elizabeth A Platz, Michael N Pollak, Robert D Schreiber, Lillian L Siu, Beverly A Teicher
No abstract text is available yet for this article.
November 1, 2022: Clinical Cancer Research
https://read.qxmd.com/read/36317369/the-aacr-journals-advancing-progress-toward-the-aacr-s-115-year-mission
#9
JOURNAL ARTICLE
Kenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, Chi Van Dang, Luis A Diaz, Raymond N DuBois, Keith T Flaherty, Philip D Greenberg, Massimo Loda, Elaine R Mardis, Elizabeth A Platz, Michael N Pollak, Robert D Schreiber, Lillian L Siu, Beverly A Teicher
No abstract text is available yet for this article.
November 1, 2022: Cancer Prevention Research
https://read.qxmd.com/read/27030389/genetic-basis-of-pd-l1-overexpression-in-diffuse-large-b-cell-lymphomas
#10
JOURNAL ARTICLE
Konstantinos Georgiou, Longyun Chen, Mattias Berglund, Weicheng Ren, Noel F C C de Miranda, Susana Lisboa, Marco Fangazio, Shida Zhu, Yong Hou, Kui Wu, Wenfeng Fang, Xianhuo Wang, Bin Meng, Li Zhang, Yixin Zeng, Govind Bhagat, Magnus Nordenskjöld, Christer Sundström, Gunilla Enblad, Riccardo Dalla-Favera, Huilai Zhang, Manuel R Teixeira, Laura Pasqualucci, Roujun Peng, Qiang Pan-Hammarström
Diffuse large B-cell lymphoma (DLBCL) is one of the most common and aggressive types of B-cell lymphoma. Deregulation of proto-oncogene expression after a translocation, most notably to the immunoglobulin heavy-chain locus (IGH), is one of the hallmarks of DLBCL. Using whole-genome sequencing analysis, we have identified the PD-L1/PD-L2 locus as a recurrent translocation partner for IGH in DLBCL. PIM1 and TP63 were also identified as novel translocation partners for PD-L1/PD-L2 Fluorescence in situ hybridization was furthermore used to rapidly screen an expanded DLBCL cohort...
June 16, 2016: Blood
https://read.qxmd.com/read/24550227/genetic-lesions-associated-with-chronic-lymphocytic-leukemia-chemo-refractoriness
#11
JOURNAL ARTICLE
Monica Messina, Ilaria Del Giudice, Hossein Khiabanian, Davide Rossi, Sabina Chiaretti, Silvia Rasi, Valeria Spina, Antony B Holmes, Marilisa Marinelli, Giulia Fabbri, Alfonso Piciocchi, Francesca R Mauro, Anna Guarini, Gianluca Gaidano, Riccardo Dalla-Favera, Laura Pasqualucci, Raul Rabadan, Robin Foà
Fludarabine refractoriness (FR) represents an unsolved clinical problem of chronic lymphocytic leukemia (CLL) management. Although next-generation sequencing studies have led to the identification of a number of genes frequently mutated in FR-CLL, a comprehensive evaluation of the FR-CLL genome has not been reported. Toward this end, we studied 10 FR-CLLs by combining whole-exome sequencing and copy number aberration (CNA) analysis, which showed an average of 16.3 somatic mutations and 4 CNAs per sample. Screening of recurrently mutated genes in 48 additional FR-CLLs revealed that ~70% of FR-CLLs carry ≥1 mutation in genes previously associated with CLL clinical course, including TP53 (27...
April 10, 2014: Blood
https://read.qxmd.com/read/21282644/signatures-of-murine-b-cell-development-implicate-yy1-as-a-regulator-of-the-germinal-center-specific-program
#12
JOURNAL ARTICLE
Michael R Green, Stefano Monti, Riccardo Dalla-Favera, Laura Pasqualucci, Nicole C Walsh, Marc Schmidt-Supprian, Jeffery L Kutok, Scott J Rodig, Donna S Neuberg, Klaus Rajewsky, Todd R Golub, Frederick W Alt, Margaret A Shipp, John P Manis
We utilized gene expression profiling of a comprehensive panel of purified developmentally defined normal murine B cells to identify unique transcriptional signatures for each subset. To elucidate transcription factor activities that function in a stage-specific fashion, we used gene sets that share transcription factor targets and found that germinal center B cells had a robust enrichment of up-regulated and down-regulated signatures compared with the other B-cell subsets. Notably, we found Yy1 and its targets to be central regulators of the germinal center B (GCB)-specific transcriptional program with binding of Yy1 to select signature genes in GCB cells, and translation of the Yy1 signatures to human GCB cells...
February 15, 2011: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/20829823/towards-patient-based-cancer-therapeutics
#13
JOURNAL ARTICLE
Stuart L Schreiber, Alykhan F Shamji, Paul A Clemons, Cindy Hon, Angela N Koehler, Benito Munoz, Michelle Palmer, Andrew M Stern, Bridget K Wagner, Scott Powers, Scott W Lowe, Xuecui Guo, Alex Krasnitz, Eric T Sawey, Raffaella Sordella, Lincoln Stein, Lloyd C Trotman, Andrea Califano, Riccardo Dalla-Favera, Adolfo Ferrando, Antonio Iavarone, Laura Pasqualucci, José Silva, Brent R Stockwell, William C Hahn, Lynda Chin, Ronald A DePinho, Jesse S Boehm, Shuba Gopal, Alan Huang, David E Root, Barbara A Weir, Daniela S Gerhard, Jean Claude Zenklusen, Michael G Roth, Michael A White, John D Minna, John B MacMillan, Bruce A Posner
No abstract text is available yet for this article.
September 2010: Nature Biotechnology
https://read.qxmd.com/read/17989719/gene-expression-profiling-suggests-primary-central-nervous-system-lymphomas-to-be-derived-from-a-late-germinal-center-b-cell
#14
JOURNAL ARTICLE
M Montesinos-Rongen, A Brunn, S Bentink, K Basso, W K Lim, W Klapper, C Schaller, G Reifenberger, J Rubenstein, O D Wiestler, R Spang, R Dalla-Favera, R Siebert, M Deckert
To characterize the molecular origin of primary lymphomas of the central nervous system (PCNSL), 21 PCNSLs of immunocompetent patients were investigated by microarray-based gene expression profiling. Comparison of the transcriptional profile of PCNSL with various normal and neoplastic B-cell subsets demonstrated PCNSL (i) to display gene expression patterns most closely related to late germinal center B cells, (ii) to display a gene expression profile similar to systemic diffuse large B-cell lymphomas (DLBCLs) and (iii) to be in part assigned to the activated B-cell-like (ABC) or the germinal center B-cell-like (GCB) subtype of DLBCL...
February 2008: Leukemia
https://read.qxmd.com/read/17828269/genotoxic-stress-regulates-expression-of-the-proto-oncogene-bcl6-in-germinal-center-b-cells
#15
JOURNAL ARTICLE
Ryan T Phan, Masumichi Saito, Yukiko Kitagawa, Anthony R Means, Riccardo Dalla-Favera
Antigen-specific B cells are selected in germinal centers, the structure in which these cells proliferate while accomplishing genome-remodeling processes such as class-switch recombination and somatic hypermutation. These events are associated with considerable genotoxic stress, which cells tolerate through suppression of DNA-damage responses by Bcl-6, a transcription factor required for the formation of germinal centers. Here we show that the expression of Bcl-6 is regulated by DNA damage through a signaling pathway that promotes Bcl-6 degradation...
October 2007: Nature Immunology
https://read.qxmd.com/read/17560272/the-role-of-activation-induced-deaminase-in-antibody-diversification-and-chromosome-translocations
#16
REVIEW
Almudena Ramiro, Bernardo Reina San-Martin, Kevin McBride, Mila Jankovic, Vasco Barreto, André Nussenzweig, Michel C Nussenzweig
Although B and T lymphocytes are similar in many respects including diversification of their antigen receptor genes by V(D)J recombination, 95% of all lymphomas diagnosed in the western world are of B-cell origin. Many of these are derived from mature B cells [Kuppers, R. (2005). Mechanisms of B-cell lymphoma pathogenesis. Nat. Rev. Cancer 5, 251-262] and display hallmark chromosome translocations involving immunoglobulin genes and a proto-oncogene partner whose expression becomes deregulated as a result of the translocation reaction [Kuppers, R...
2007: Advances in Immunology
https://read.qxmd.com/read/16329192/new-insights-into-the-phenotype-and-cell-derivation-of-b-cell-chronic-lymphocytic-leukemia
#17
REVIEW
U Klein, R Dalla-Favera
For many decades, B cell chronic lymphocytic leukemia (B-CLL) stood out as a B cell-derived malignancy that was difficult to position within the framework of the available B cell differentiation scheme: First, the histology as well as the immunophenotype did not quite resemble that of any normal lymphocyte; second, in contrast to almost all other B cell tumor subtypes, the immunoglobulin variable region (IgV) genes of B-CLL cases could be either unmutated or somatically mutated; third, the genomic lesions observed in B-CLL were markedly distinct from those of the other major B cell malignancies, which typically exhibit balanced chromosome translocations...
2005: Current Topics in Microbiology and Immunology
https://read.qxmd.com/read/15870177/nfkappab-activity-function-and-target-gene-signatures-in-primary-mediastinal-large-b-cell-lymphoma-and-diffuse-large-b-cell-lymphoma-subtypes
#18
JOURNAL ARTICLE
Friedrich Feuerhake, Jeffery L Kutok, Stefano Monti, Wen Chen, Ann S LaCasce, Giorgio Cattoretti, Paul Kurtin, Geraldine S Pinkus, Laurence de Leval, Nancy L Harris, Kerry J Savage, Donna Neuberg, Thomas M Habermann, Riccardo Dalla-Favera, Todd R Golub, Jon C Aster, Margaret A Shipp
Primary mediastinal large B-cell lymphoma (MLBCL) shares important clinical and molecular features with classic Hodgkin lymphoma, including nuclear localization of the nuclear factor kappaB (NFkappaB) subunit c-REL (reticuloendotheliosis viral oncogene homolog) in a pilot series. Herein, we analyzed c-REL subcellular localization in additional primary MLBCLs and characterized NFkappaB activity and function in a MLBCL cell line. The new primary MLBCLs had prominent c-REL nuclear staining, and the MLBCL cell line exhibited high levels of NFkappaB binding activity...
August 15, 2005: Blood
https://read.qxmd.com/read/15550490/molecular-profiling-of-diffuse-large-b-cell-lymphoma-identifies-robust-subtypes-including-one-characterized-by-host-inflammatory-response
#19
JOURNAL ARTICLE
Stefano Monti, Kerry J Savage, Jeffery L Kutok, Friedrich Feuerhake, Paul Kurtin, Martin Mihm, Bingyan Wu, Laura Pasqualucci, Donna Neuberg, Ricardo C T Aguiar, Paola Dal Cin, Christine Ladd, Geraldine S Pinkus, Gilles Salles, Nancy Lee Harris, Riccardo Dalla-Favera, Thomas M Habermann, Jon C Aster, Todd R Golub, Margaret A Shipp
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with recognized variability in clinical outcome, genetic features, and cells of origin. To date, transcriptional profiling has been used to highlight similarities between DLBCL tumor cells and normal B-cell subtypes and associate genes and pathways with unfavorable outcome. To identify robust and highly reproducible DL-BCL subtypes with comprehensive transcriptional signatures, we used a large series of newly diagnosed DLBCLs, whole genome arrays, and multiple clustering methods...
March 1, 2005: Blood
https://read.qxmd.com/read/15507667/rt-pcr-analysis-of-rna-extracted-from-bouin-fixed-and-paraffin-embedded-lymphoid-tissues
#20
JOURNAL ARTICLE
Annunziata Gloghini, Barbara Canal, Ulf Klein, Luigino Dal Maso, Tiziana Perin, Riccardo Dalla-Favera, Antonino Carbone
In the present study, we have investigated whether RNA can be efficiently isolated from Bouin-fixed or formalin-fixed, paraffin-embedded lymphoid tissue specimens. To this aim, we applied a new and simple method that includes the combination of proteinase K digestion and column purification. By this method, we demonstrated that the amplification of long fragments could be accomplished after a pre-heating step before cDNA synthesis associated with the use of enzymes that work at high temperature. By means of PCR using different primers for two examined genes (glyceraldehyde-3-phosphate dehydrogenase [GAPDH]- and CD40), we amplified segments of cDNA obtained by reverse transcription of the isolated RNA extracted from Bouin-fixed or formalin-fixed paraffin-embedded tissues...
November 2004: Journal of Molecular Diagnostics: JMD
keyword
keyword
17472
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.